Skip to main content
Caplight Logo









Experic

Experic

Private
East Windsor, ConnecticutHealthcare & Life Scienceshttps://expericservices.com/

Last Round

Growth Equity

Oct 29, 2024

Total Funding Raised

$14M

Company Overview

Experic is a contract development and manufacturing organization (CDMO) and clinical trial supply services company that supports pharmaceutical and biopharmaceutical companies across the product life cycle.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Pharma Supply Chain, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

contract development and manufacturing organizationCDMOpharmaceutical manufacturingclinical trial supplyinhalation productspowder handlingGMP manufacturingdrug packagingpharmaceutical outsourcingformulation developmentclinical supply chainbiotech manufacturinganalytical servicesdrug commercializationwhite label pharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Experic Comparables

Compare Experic with similar companies based on industry and business-model similarity.

Experic comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mikart
87%
TriRx Pharmaceutical Services
83%
Bend Bioscience
82%

Experic Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityOct 29, 2024
Series B ExtensionOct 5, 2023
Series BNov 30, 2022

Key People

Founding team and executive leadership

Matthew Mollan

Chief Executive Officer

Executive Team

Anthony Asfor

Interim Chief Financial Officer

Executive Team

Jeffrey Shane

Chief Commercial Officer, Board Member

Executive Team

Experic Investors

Notable investors and investment history

Experic investors
InvestorRounds
Kineticos VenturesSeries B, Growth Equity
1315 CapitalGrowth Equity
East Seattle PartnersGrowth Equity, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors increased 57% MoM, reaching 4.4K.

  • Apr 10, 2025

    Monthly visitors grew 32% MoM, reaching 2.5K.

Experic Filings

Explore SEC and related filing metadata, where available.

Experic filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Experic's valuation, stock price, and market status.

Is Experic a public or private company?

Experic is a private company.

What is the current stock price of Experic?

Experic is a private company with no public stock price. No recent secondary market data is available.

How much is Experic worth (valuation)?

Valuation information for Experic is not publicly available.

Can I buy Experic stock?

Experic shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Experic's last funding round?

Experic's most recent funding round was Growth Equity on October 29, 2024.

Who are the main investors in Experic?

Key investors in Experic include 1315 Capital, East Seattle Partners.

Will Experic IPO soon?

No public IPO plans have been announced for Experic.

How can I track Experic secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Experic's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEast Windsor, Connecticut
Employee Range62
Year Founded2015
Last FundingOct 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?